Literature DB >> 11804647

Apoptosis: a guide for the perplexed.

Robert S Sloviter1.   

Abstract

The term 'apoptosis' describes an active process of cellular deconstruction originally contrasted morphologically with necrosis. The mistaken equivalence of the terms apoptosis and 'programmed cell death' has caused confusion and implied that apoptosis is an identifiable therapeutic target rather than a name of a type of cell death. The roots of confusion are suggested to lie not in superficial disagreements about the morphology and biochemistry of cell death, but in the lamentable disconnection of modern science from its philosophical foundations (i.e. Socratic definition, nominalism versus realism, and William of Ockham's advocacy of Aristotelian metaphysics over Plato's Theory of Forms). Renewed awareness of these issues might be the key to understanding that apoptosis is a created concept, not a real entity, and that the use of terms that defy definition has become an obstacle to clear thinking about preventable cell death.

Entities:  

Mesh:

Year:  2002        PMID: 11804647     DOI: 10.1016/s0165-6147(00)01867-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  12 in total

Review 1.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Death receptor 5 and neuroproliferation.

Authors:  Yanli Niu; Yongqiang Li; Jianfeng Zang; Hongen Huang; Jiexin Deng; Zhanjun Cui; Dongming Yu; Jinbo Deng
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 3.  Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem.

Authors:  Robert S Sloviter; Argyle V Bumanglag
Journal:  Neuropharmacology       Date:  2012-02-04       Impact factor: 5.250

Review 4.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

5.  Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.

Authors:  Lee J Martin
Journal:  Pharmaceuticals (Basel)       Date:  2010

Review 6.  Cell death mechanisms and modulation in traumatic brain injury.

Authors:  Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

7.  Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype.

Authors:  Joanna Fombonne; Stéphanie Reix; Ramahefarizo Rasolonjanahary; Emmanuelle Danty; Sylvie Thirion; Geneviéve Laforge-Anglade; Olivier Bosler; Patrick Mehlen; Alain Enjalbert; Slavica Krantic
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

Review 8.  Photoreceptor cell death mechanisms in inherited retinal degeneration.

Authors:  Javier Sancho-Pelluz; Blanca Arango-Gonzalez; Stefan Kustermann; Francisco Javier Romero; Theo van Veen; Eberhart Zrenner; Per Ekström; François Paquet-Durand
Journal:  Mol Neurobiol       Date:  2008-11-04       Impact factor: 5.590

Review 9.  Vascular dementia: pharmacological treatment approaches and perspectives.

Authors:  Andrius Baskys; Anthony C Hou
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3.

Authors:  Srinivasa Subramaniam; Ute Zirrgiebel; Oliver von Bohlen Und Halbach; Jens Strelau; Christine Laliberté; David R Kaplan; Klaus Unsicker
Journal:  J Cell Biol       Date:  2004-05-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.